Alpha Cognition Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
02074J501
SEDOL
N/A
CIK
N/A
LEI:
FIGI: BBG00L7TXMM3
ACOG
Alpha Cognition Inc.
GICS: -
·
Sector: EQTY
·
Sub-Sector: -
NAME
Alpha Cognition Inc.
ISIN
CA02074J5017
TICKER
ACOG
MIC
XNAS
REUTERS
ACOG.OQ
BLOOMBERG
ACOG US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Wed, 08.01.2025
Alpha Cognition
CA02074J5017
Alpha Cognition, Inc. (Nasdaq: ACOG) (“ACI” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, and China Medical System Holdings Limited (CMS) (867.HK), a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capabili...
Alpha Cognition
Mon, 06.01.2025
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced it will host an investor update call on Tuesday, January 28th, 2025 at 4pm EST to present its commercial launch strategy for ZUNVEYL (benzgalant...
Alpha Cognition
Mon, 16.12.2024
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced that the underwriters of its underwritten U.S. public offering (the “Offering”) have partially exercised their over-allotment option to purchase...
Alpha Cognition
Fri, 13.12.2024
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, or the “Company”), announces that in connection with the Company’s listing on the Nasdaq Capital Market the Company will voluntarily delist its common shares from the Canadian Securities Exchange.
The shares will be delisted from the Canadian Securities Exchange at the close of trading on D...
Alpha Cognition
Wed, 11.12.2024
Alpha Cognition
CA02074J5017
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders, today announced interim preclinical data that supports the continued development of ALPHA-1062 for the treatment of mild traumatic brain injury (mTBI). The...
Alpha Cognition
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
